1-1 of 1
Salaheddine Bouhya, MD
Close
Sort by
Journal Articles

Bortezomib Overcomes Usual Prognosis Factor in Patients with Multiple Myeloma (MM) Having High Dose Therapy (HDT)

Sophie Auger, MD, Philippe Quittet, MD, Salaheddine Bouhya, MD, Tarik Kanouni, MD, Pascal Latry, MD, Mattea Orsini, Jean-Francois Rossi, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3104.
https://doi.org/10.1182/blood.V118.21.3104.3104
Published: 2011